Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

Free Radical Research

Volumn 46, Issue 4, 2012, Pages 565-576

  Santos, Renato X ^a,b   Correia, Sönia C ^a,b   Zhu, Xiongwei ^c   Lee, Hyoung Gon ^c   Petersen, Robert B ^c   Nunomura, Akihiko ^d   Smith, Mark A ^c   Perry, George ^e,g   Moreira, Paula I ^a,f  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g University of San Antonio   (United States)

Author keywords

8 hydroxyguanine; BER; Hydroxyl radical; Mitochondria; Nucleus

Indexed keywords

ANTIOXIDANT; CELL NUCLEUS DNA; METAL; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA REPAIR; HOMEOSTASIS; HUMAN; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; REVIEW;

ALZHEIMER DISEASE; CELL NUCLEUS; DNA DAMAGE; DNA, MITOCHONDRIAL; HUMANS; OXIDATIVE STRESS;

EID: 84863229887     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.648188     Document Type: Review

References (179)

1. Ittner LM, Gotz J. Amyloid-beta and tau-a toxic pas de deux in Alzheimer ' s disease. Nat Rev Neurosci 2011;12:65-72.
2. Querfurth HW, LaFerla FM. Alzheimer' s disease. N Engl J Med 2010;362:329-344.
3. Santos RX, Moreira PI. mTOR is a potential therapeutic target for Alzhiemer ' s disease. In: Sun M-K, editor. Cognitive Sciences. Hauppauge, NY: Nova Science Publishers, Inc.; 2012. in press.
4. Eisenstein M. Genetics: fi nding risk factors. Nature 2011; 475:S20-S22.
5. Swerdlow RH, Burns JM, Khan SM. The Alzheimer' s disease mitochondrial cascade hypothesis. J Alzheimers Dis 2010;20(Suppl 2):S265-279.
6. Santos RX, Correia SC, Wang X, Perry G, Smith MA, Moreira PI, Zhu X. Alzheimer ' s disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 2010;3:570-581.
7. Butterfi eld DA, Poon HF, St Clair D, Keller JN, Pierce WM, Klein JB, Markesbery WR. Redox proteomics identifi cation of oxidatively modifi ed hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer ' s disease. Neurobiol Dis 2006;22:223-232.
8. Ding Q, Markesbery WR, Chen Q, Li F, Keller JN. Ribosome dysfunction is an early event in Alzheimer ' s disease. J Neurosci 2005;25:9171-9175. (Pubitemid 41500825)
9. Keller JN, Schmitt FA, Scheff SW, Ding Q, Chen Q, Butterfi eld DA, Markesbery WR. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005;64:1152-1156.
10. Markesbery WR, Kryscio RJ, Lovell MA, Morrow JD. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005;58:730-735. (Pubitemid 41552548)
11. Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006;96:825-832.
12. Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 2005;26:567-573. (Pubitemid 40228745)
13. Baldeiras I, Santana I, Proenca MT, Garrucho MH, Pascoal R, Rodrigues A, Duro D, Oliveira CR. Oxidative damage and progression to Alzheimer ' s disease in patients with mild cognitive impairment. J Alzheimers Dis 2010;21:1165-1177.
14. Lovell MA, Soman S, Bradley MA. Oxidatively modifi ed nucleic acids in preclinical Alzheimer ' s disease (PCAD) brain. Mech Ageing Dev 2011;132:443-448.
15. Gallagher JJ, Finnegan ME, Grehan B, Dobson J, Collingwood JF, Lynch MA. Modest amyloid deposition is associated with iron dysregulation, microglial activation, and oxidative stress. J Alzheimers Dis 2011;doi: 10.3233/JAD-2011-110614.
16. Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6:551-559.
17. Moreira PI, Duarte AI, Santos MS, Rego AC, Oliveira CR. An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer ' s disease. J Alzheimers Dis 2009;16:741-761.
18. Simm A, Brö m me H-J. Reactive oxygen species (ROS) and aging: do we need them-can we measure them-should we block them? Signal Transd 2005;5:115-125. (Pubitemid 41168380)
19. Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010;12:503-535.
20. Sayre LM, Perry G, Smith MA. Oxidative stress and neurotoxicity. Chem Res Toxicol 2008;21:172-188. (Pubitemid 351219718)
21. Halliwell B, Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 1994;102(Suppl 10):5-12.
22. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. (Pubitemid 44566469)
23. Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, Smith MA, Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 2008;44: 1493-1505.
24. Mao P, Reddy PH. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer ' s disease: implications for early intervention and therapeutics. Biochim Biophys Acta 2011;1812:1359-1370.
25. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer ' s disease. Nucleic Acids Res 2007;35:7497-7504.
26. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer disease. Free Radic Biol Med 2009;46:1241-1249.
27. Scheffl er IE. Mitochondria. Hoboken, NJ: John Wiley & Sons, Inc.; 2008.
28. Nelson DL, Cox MM. Lehninger Principles of Biochemistry. New York: W.H. Freeman; 2004.
29. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979;59:527-605. (Pubitemid 9236599)
30. Moreira PI, Zhu X, Wang X, Lee HG, Nunomura A, Petersen RB, Perry G, Smith MA. Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 2010;1802: 212-220.
31. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009;417:1-13.
32. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 2003;552:335-344. (Pubitemid 37321833)
33. Han D, Antunes F, Canali R, Rettori D, Cadenas E. Voltagedependent anion channels control the release of the superoxide anion from mitochondria to cytosol. J Biol Chem 2003;278:5557-5563. (Pubitemid 36800797)
34. Muller FL, Liu Y, Van Remmen H. Complex III releases superoxide to both sides of the inner mitochondrial membrane. J Biol Chem 2004;279:49064-49073. (Pubitemid 39625788)
35. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407. (Pubitemid 43011120)
36. Green K, Brand MD, Murphy MP. Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004;53(Suppl 1):S110-S118. (Pubitemid 38168702)
37. Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010;35:505-513.
38. Ribe EM, Serrano-Saiz E, Akpan N, Troy CM. Mechanisms of neuronal death in disease: defi ning the models and the players. Biochem J 2008;415:165-182.
39. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, et al. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 2007;66:525-532. (Pubitemid 46869694)
40. Fattoretti P, Balietti M, Casoli T, Giorgetti B, Di Stefano G, Bertoni-Freddari C, Lattanzio F, Sensi SL. Decreased numeric density of succinic dehydrogenase-positive mitochondria in CA1 pyramidal neurons of 3xTg-AD mice. Rejuvenation Res 2010;13:144-147.
41. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 2009;30:1574-1586.
42. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD. Mitochondrial bioenergetic defi cit precedes Alzheimer ' s pathology in female mouse model of Alzheimer ' s disease. Proc Nat Acad Sci USA 2009;106:14670-14675.
43. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006;443: 787-795. (Pubitemid 44622683)
44. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759-767. (Pubitemid 32678256)
45. Reddy PH, Beal MF. Are mitochondria critical in the pathogenesis of Alzheimer ' s disease? Brain Res Brain Res Rev 2005;49:618-632. (Pubitemid 41546661)
46. Moreira PI, Carvalho C, Zhu X, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer ' s disease pathophysiology. Biochim Biophys Acta 2010;1802:2-10.
47. Maurer I, Zierz S, Moller HJ. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 2000;21:455-462. (Pubitemid 30349116)
48. Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G. Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 1999;370:236-239. (Pubitemid 29491430)
49. Parker WD Jr. Cytochrome oxidase defi ciency in Alzheimer' s disease. Ann NY Acad Sci 1991;640:59-64.
50. T akuma K, Fang F, Zhang W, Yan S, Fukuzaki E, Du H, et al. RAGE-mediated signaling contributes to intraneuronal transport of amyloid-beta and neuronal dysfunction. Proc Natl Acad Sci USA 2009;106:20021-20026.
51. Humpel C, Marksteiner J. Cerebrovascular damage as a cause for Alzheimer ' s disease. Curr Neurovasc Res 2005;2: 341-347. (Pubitemid 41297371)
52. Atamna H, Frey WH 2nd. A role for heme in Alzheimer' s disease: heme binds amyloid beta and has altered metabolism. Proc Natl Acad Sci USA 2004;101:11153-11158. (Pubitemid 38989599)
53. Atamna H. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer ' s disease. J Alzheimers Dis 2006;10: 255-266. (Pubitemid 44763996)
54. Takuma K, Yao J, Huang J, Xu H, Chen X, Luddy J, et al. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 2005;19:597-598. (Pubitemid 40471256)
55. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer ' s disease. Science 2004;304:448-452. (Pubitemid 38495942)
56. Yang TT, Hsu CT, Kuo YM. Amyloid precursor protein, heat-shock proteins, and Bcl-2 form a complex in mitochondria and modulate mitochondria function and apoptosis in N2a cells. Mech Ageing Dev 2009;130:592-601.
57. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 1997;94:14900-14905. (Pubitemid 28041472)
58. Coskun PE, Beal MF, Wallace DC. Alzheimer' s brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci USA 2004;101:10726-10731. (Pubitemid 38955810)
59. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fi ssion/fusion proteins. Proc Natl Acad Sci USA 2008;105:19318-19323.
60. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X. Impaired balance of mitochondrial fi ssion and fusion in Alzheimer ' s disease. J Neurosci 2009;29:9090-9103.
61. Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer ' s disease: implications for neuronal damage. Hum Mol Genet 2011;20:2495-2509.
62. Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer ' s disease. Hum Mol Genet 2011;20:4515-4529.
63. Sheng B, Wang X, Su B, Lee HG, Casadesus G, Perry G, Zhu X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer ' s disease. J Neurochem 2011; doi: 10.1111/j.1471-4159.2011.07581.x.
64. Budimir A. Metal ions, Alzheimer' s disease and chelation therapy. Acta Pharm 2011;61:1-14.
65. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, Gunshin H, et al. An iron-responsive element type II in the 5-untranslated region of the Alzheimer ' s amyloid precursor protein transcript. J Biol Chem 2002;277:45518-45528. (Pubitemid 36159162)
66. Smith MA, Zhu X, Tabaton M, Liu G, McKeel DW Jr, Cohen ML, et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimers Dis 2010;19:363-372.
67. Lavados M, Guillon M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J Alzheimers Dis 2008;13:225-232. (Pubitemid 352038527)
68. Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 2008;7:3-10. (Pubitemid 351516211)
69. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redoxactive metals, oxidative stress, and Alzheimer ' s disease pathology. Ann N Y Acad Sci 2004;1012:153-163. (Pubitemid 38453522)
70. Liu B, Moloney A, Meehan S, Morris K, Thomas SE, Serpell LC, et al. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J Biol Chem 2011;286:4248-4256.
71. Bolognin S, Messori L, Drago D, Gabbiani C, Cendron L, Zatta P. Aluminum, copper, iron and zinc differentially alter amyloid-Abeta(1-42) aggregation and toxicity. Int J Biochem Cell Biol 2011;43:877-885.
72. Chen WT, Liao YH, Yu HM, Cheng IH, Chen YR. Distinct effects of Zn2, Cu2, Fe3, and Al3on amyloid-beta stability, oligomerization, and aggregation: amyloid-beta destabilization promotes annular protofi bril formation. J Biol Chem 2011;286:9646-9656.
73. Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011;283:65-87.
74. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofi brillary tangles and senile plaques in Alzheimer ' s disease: a central role for bound transition metals. J Neurochem 2000;74:270-279. (Pubitemid 30012778)
75. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, et al. The A beta peptide of Alzheimer ' s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry (Mosc) 1999;38: 7609-7616. (Pubitemid 29289332)
76. Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in Alzheimer ' s disease. J Am Geriatr Soc 2003;51:1143-1148. (Pubitemid 36993474)
77. Block ML. NADPH oxidase as a therapeutic target in Alzheimer ' s disease. BMC Neurosci 2008;9(Suppl 2):S8.
78. Simonyi A, He Y, Sheng W, Sun AY, Wood WG, Weisman GA, Sun GY. Targeting NADPH oxidase and phospholipases A2 in Alzheimer ' s disease. Mol Neurobiol 2010;41:73-86.
79. Babior BM. NADPH oxidase. Curr Opin Immunol 2004;16:42-47. (Pubitemid 38198116)
80. Zhu X, Su B, Wang X, Smith MA, Perry G. Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 2007;64: 2202-2210. (Pubitemid 47347959)
81. Sorce S, Krause KH. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 2009;11:2481-2504.
82. Klegeris A, McGeer PL. Beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate. J Neurosci Res 1997;49:229-235. (Pubitemid 27332721)
83. Shelat PB, Chalimoniuk M, Wang JH, Strosznajder JB, Lee JC, Sun AY, Simonyi A, Sun GY. Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons. J Neurochem 2008;106:45-55. (Pubitemid 351840199)
84. Van Muiswinkel FL, Veerhuis R, Eikelenboom P. Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 1996;66:2468-2476. (Pubitemid 26159083)
85. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Infl ammation and Alzheimer ' s disease. Neurobiol Aging 2000;21:383-421.
86. Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, et al. NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 2010;12: 1371-1382.
87. Ansari MA, Scheff SW. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic Biol Med 2011;51:171-178.
88. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer ' s disease. Nat Rev Neurosci 2004;5: 347-360. (Pubitemid 38568496)
89. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad Sci USA 2008;105: 1347-1352. (Pubitemid 351397056)
90. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, Carlson GA, Iadecola C. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. J Neurosci 2005;25: 1769-1777. (Pubitemid 40279282)
91. Dumont M, Lin MT, Beal MF. Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer ' s disease. J Alzheimers Dis 2010;20(Suppl 2):S633-S643.
92. Li F, Calingasan NY, Yu F, Mauck WM, Toidze M, Almeida CG, et al. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 2004; 89:1308-1312. (Pubitemid 38715849)
93. Melov S, Adlard PA, Morten K, Johnson F, Golden TR, Hinerfeld D, et al. Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2007;2:e536.
94. Esposito L, Raber J, Kekonius L, Yan F, Yu GQ, Bien-Ly N, et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer ' s disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 2006;26: 5167-5179. (Pubitemid 44315298)
95. Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT. Reduction of oxidative stress, amyloid deposition, and memory defi cit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer ' s disease. FASEB J 2009;23:2459-2466.
96. Massaad CA, Washington TM, Pautler RG, Klann E. Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory defi cits in a mouse model of Alzheimer ' s disease. Proc Natl Acad Sci USA 2009;106:13576-13581.
97. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer ' s disease. Exp Neurol 1998;150:40-44. (Pubitemid 28146421)
98. Straface E, Matarrese P, Gambardella L, Vona R, Sgadari A, Silveri MC, Malorni W. Oxidative imbalance and cathepsin D changes as peripheral blood biomarkers of Alzheimer disease: a pilot study. FEBS Lett 2005;579:2759-2766. (Pubitemid 40725242)
99. Schuessel K, Schafer S, Bayer TA, Czech C, Pradier L, Muller-Spahn F, Muller WE, Eckert A. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice. Neurobiol Dis 2005;18:89-99. (Pubitemid 40092899)
100. Habib LK, Lee MT, Yang J. Inhibitors of catalase-amyloid interactions protect cells from beta-amyloid-induced oxidative stress and toxicity. J Biol Chem 2010;285: 38933-38943.
101. Hyun DH, Hernandez JO, Mattson MP, de Cabo R. The plasma membrane redox system in aging. Ageing Res Rev 2006;5:209-220. (Pubitemid 43766257)
102. Hyun DH, Hunt ND, Emerson SS, Hernandez JO, Mattson MP, de Cabo R. Up-regulation of plasma membraneassociated redox activities in neuronal cells lacking functional mitochondria. J Neurochem 2007;100:1364-1374.
103. Navas P, Villalba JM, de Cabo R. The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 2007;7(Suppl):S34-40. (Pubitemid 46722290)
104. Rodriguez-Aguilera JC, Lopez-Lluch G, Santos-Ocana C, Villalba JM, Gomez-Diaz C, Navas P. Plasma membrane redox system protects cells against oxidative stress. Redox Rep 2000;5:148-150.
105. Villalba JM, Navas P. Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid Redox Signal 2000;2:213-230. (Pubitemid 30445934)
106. Hyun DH, Mughal MR, Yang H, Lee JH, Ko EJ, Hunt ND, de Cabo R, Mattson MP. The plasma membrane redox system is impaired by amyloid beta-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice. Exp Neurol 2010;225:423-429.
107. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR. Brain oxidative stress in a tripletransgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008;44:2051-2057.
108. Nishida Y, Ito S, Ohtsuki S, Yamamoto N, Takahashi T, Iwata N, et al. Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease. J Biol Chem 2009; 284:33400-33408.
109. Gu M, Owen AD, Toffa SE, Cooper JM, Dexter DT, Jenner P, Marsden CD, Schapira AH. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. J Neurol Sci 1998;158:24-29. (Pubitemid 28277530)
110. Bermejo P, Martin-Aragon S, Benedi J, Susin C, Felici E, Gil P, Ribera JM, Villar AM. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer ' s disease from mild cognitive impairment. Free Radic Res 2008;42:162-170. (Pubitemid 351298365)
111. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer ' s disease. Neurobiol Aging 2003;24:915-919. (Pubitemid 36962976)
112. Cardoso SM, Oliveira CR. Glutathione cycle impairment mediates A beta-induced cell toxicity. Free Radic Res 2003;37:241-250. (Pubitemid 36181880)
113. Svilar D, Goellner EM, Almeida KH, Sobol RW. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal 2011;14: 2491-2507.
114. Pisoni RL, Acker TL, Lisowski KM, Lemons RM, Thoene JG. A cysteine-specifi c lysosomal transport system provides a major route for the delivery of thiol to human fi broblast lysosomes: possible role in supporting lysosomal proteolysis. J Cell Biol 1990;110:327-335.
115. Brun A, Brunk U. Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem 1970;18:820-827.
116. Petrat F, de Groot H, Rauen U. Subcellular distribution of chelatable iron: a laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochem J 2001;356:61-69. (Pubitemid 34275706)
117. Schafer FQ, Buettner GR. Acidic pH amplifi es ironmediated lipid peroxidation in cells. Free Radic Biol Med 2000;28:1175-1181. (Pubitemid 30417459)
118. Tenopoulou M, Doulias PT, Barbouti A, Brunk U, Galaris D. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis. Biochem J 2005;387:703-710. (Pubitemid 40685704)
119. Kurz T, Leake A, Von Zglinicki T, Brunk UT. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage. Biochem J 2004;378: 1039-1045. (Pubitemid 38406883)
120. Ditaranto K, Tekirian TL, Yang AJ. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer ' s disease. Neurobiol Dis 2001;8:19-31. (Pubitemid 32171815)
121. Yang AJ, Chandswangbhuvana D, Margol L, Glabe CG. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J Neurosci Res 1998;52:691-698. (Pubitemid 28300049)
122. Jeppesen DK, Bohr VA, Stevnsner T. DNA repair defi-ciency in neurodegeneration. Prog Neurobiol 2011;94: 166-200.
123. Dizdaroglu M, Kirkali G, Jaruga P. Formamidopyrimidines in DNA: mechanisms of formation, repair, and biological effects. Free Radic Biol Med 2008;45:1610-1621.
124. Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137-2145.
125. Maki H. Origins of spontaneous mutations: specifi city and directionality of base-substitution, frameshift, and sequencesubstitution mutageneses. Annu Rev Genet 2002;36: 279-303.
126. O' C onnor TR, Boiteux S, Laval J. Ring-opened 7-methylguanine residues in DNA are a block to in vitro DNA synthesis. Nucleic Acids Res 1988;16:5879-5894.
127. Malins DC, Hellstrom KE, Anderson KM, Johnson PM, Vinson MA. Antioxidant-induced changes in oxidized DNA. Proc Natl Acad Sci USA 2002;99:5937-5941. (Pubitemid 34493243)
128. Neeley WL, Essigmann JM. Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem Res Toxicol 2006;19:491-505.
129. Hailer MK, Slade PG, Martin BD, Rosenquist TA, Sugden KD. Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2. DNA Repair (Amst) 2005;4:41-50. (Pubitemid 39469081)
130. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 2003;17:1195-1214. (Pubitemid 36775767)
131. Steenken S. Purine bases, nucleosides, and nucleotides: aqueous solution redox chemistry and transformation reactions of their radical cations and e-and OH adducts. Chem Rev 1989;89:503-520.
132. Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 2005;591:45-59. (Pubitemid 41654839)
133. Weissman L, de Souza-Pinto NC, Stevnsner T, Bohr VA. DNA repair, mitochondria, and neurodegeneration. Neuroscience 2007;145:1318-1329. (Pubitemid 46602727)
134. Huffman JL, Sundheim O, Tainer JA. DNA base damage recognition and removal: new twists and grooves. Mutat Res 2005;577:55-76. (Pubitemid 41225489)
135. Stivers JT, Jiang YL. A mechanistic perspective on the chemistry of DNA repair glycosylases. Chem Rev 2003;103: 2729-2759.
136. Morland I, Rolseth V, Luna L, Rognes T, Bjoras M, Seeberg E. Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res 2002;30:4926-4936. (Pubitemid 35414653)
137. Hazra TK, Izumi T, Boldogh I, Imhoff B, Kow YW, Jaruga P, Dizdaroglu M, Mitra S. Identifi cation and characterization of a human DNA glycosylase for repair of modifi ed bases in oxidatively damaged DNA. Proc Natl Acad Sci USA 2002;99:3523-3528. (Pubitemid 34252141)
138. Ide H, Kotera M. Human DNA glycosylases involved in the repair of oxidatively damaged DNA. Biol Pharm Bull 2004;27:480-485. (Pubitemid 41701830)
139. Klungland A, Rosewell I, Hollenbach S, Larsen E, Daly G, Epe B, et al. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc Natl Acad Sci USA 1999;96:13300-13305.
140. de Souza-Pinto NC, Eide L, Hogue BA, Thybo T, Stevnsner T, Seeberg E, Klungland A, Bohr VA. Repair of 8-oxodeoxyguanosine lesions in mitochondrial dna depends on the oxoguanine dna glycosylase (OGG1) gene and 8-oxoguanine accumulates in the mitochondrial dna of OGG1-defective mice. Cancer Res 2001;61:5378-5381. (Pubitemid 32694914)
141. Demple B, Sung JS. Molecular and biological roles of Ape1 protein in mammalian base excision repair. DNA Repair (Amst) 2005;4:1442-1449. (Pubitemid 41653305)
142. Wilson DM 3rd, Barsky D. The major human abasic endonuclease: formation, consequences and repair of abasic lesions in DNA. Mutat Res 2001;485:283-307. (Pubitemid 32406284)
143. Bohr VA. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic Biol Med 2002;32:804-812. (Pubitemid 34439251)
144. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-465. (Pubitemid 11159074)
145. Stowe DF, Camara AK. Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function. Antioxid Redox Signal 2009;11: 1373-1414.
146. Yakes FM, Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997;94:514-519. (Pubitemid 27053665)
147. Nilsen H, Otterlei M, Haug T, Solum K, Nagelhus TA, Skorpen F, Krokan HE. Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. Nucleic Acids Res 1997;25:750-755. (Pubitemid 27299828)
148. Nishioka K, Ohtsubo T, Oda H, Fujiwara T, Kang D, Sugimachi K, Nakabeppu Y. Expression and differential intracellular localization of two major forms of human 8-oxoguanine DNA glycosylase encoded by alternatively spliced OGG1 mRNAs. Mol Biol Cell 1999;10:1637-1652. (Pubitemid 29230914)
149. Hu J, de Souza-Pinto NC, Haraguchi K, Hogue BA, Jaruga P, Greenberg MM, Dizdaroglu M, Bohr VA. Repair of formamidopyrimidines in DNA involves different glycosylases: role of the OGG1, NTH1, and NEIL1 enzymes. J Biol Chem 2005;280:40544-40551. (Pubitemid 41780543)
150. Fung H, Kow YW, Van Houten B, Taatjes DJ, Hatahet Z, Janssen YM, et al. Asbestos increases mammalian APendonuclease gene expression, protein levels, and enzyme activity in mesothelial cells. Cancer Res 1998;58:189-194. (Pubitemid 28047051)
151. Rivkees SA, Kelley MR. Expression of a multifunctional DNA repair enzyme gene, apurinic/apyrimidinic endonuclease (APE; Ref-1) in the suprachiasmatic, supraoptic and paraventricular nuclei. Brain Res 1994;666:137-142. (Pubitemid 24359666)
152. Wilson TM, Rivkees SA, Deutsch WA, Kelley MR. Differential expression of the apurinic/apyrimidinic endonuclease (APE/ref-1) multifunctional DNA base excision repair gene during fetal development and in adult rat brain and testis. Mutat Res 1996;362:237-248. (Pubitemid 26102977)
153. Lakshmipathy U, Campbell C. Mitochondrial DNA ligase III function is independent of Xrcc1. Nucleic Acids Res 2000;28:3880-3886.
154. Lakshmipathy U, Campbell C. The human DNA ligase III gene encodes nuclear and mitochondrial proteins. Mol Cell Biol 1999;19:3869-3876. (Pubitemid 29193846)
155. Hansen AB, Griner NB, Anderson JP, Kujoth GC, Prolla TA, Loeb LA, Glick E. Mitochondrial DNA integrity is not dependent on DNA polymerase-beta activity. DNA Repair (Amst) 2006;5:71-79. (Pubitemid 41832513)
156. Kaguni LS. DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem 2004;73:293-320. (Pubitemid 39050371)
157. Intano GW, McMahan CA, McCarrey JR, Walter RB, McKenna AE, Matsumoto Y, et al. Base excision repair is limited by different proteins in male germ cell
158. Intano GW, Cho EJ, McMahan CA, Walter CA. Age-related base excision repair activity in mouse brain and liver nuclear extracts. J Gerontol A Biol Sci Med Sci 2003;58:205-211. (Pubitemid 36307590)
159. Imam SZ, Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an agedependent manner. Neurobiol Aging 2006;27:1129-1136. (Pubitemid 43850641)
160. Chen D, Cao G, Hastings T, Feng Y, Pei W, O' H oro C, Chen J. Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J Neurochem 2002;81: 1273-1284. (Pubitemid 34809261)
161. Szczesny B, Bhakat KK, Mitra S, Boldogh I. Age-dependent modulation of DNA repair enzymes by covalent modifi cation and subcellular distribution. Mech Ageing Dev 2004;125:755-765. (Pubitemid 39482404)
162. Hegde ML, Hegde PM, Holthauzen LM, Hazra TK, Rao KS, Mitra S. Specifi c Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases. J Biol Chem 2010;285:28812-28825.
163. Cabelof DC, Raffoul JJ, Ge Y, Van Remmen H, Matherly LH, Heydari AR. Age-related loss of the DNA repair response following exposure to oxidative stress. J Gerontol A Biol Sci Med Sci 2006;61:427-434. (Pubitemid 43794700)
164. Szczesny B, Hazra TK, Papaconstantinou J, Mitra S, Boldogh I. Age-dependent defi ciency in import of mitochondrial DNA glycosylases required for repair of oxidatively damaged bases. Proc Natl Acad Sci USA 2003;100: 10670-10675. (Pubitemid 37140086)
165. Du Y, Wooten MC, Gearing M, Wooten MW. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radic Biol Med 2009;46:492-501.
166. Nakaso K, Yoshimoto Y, Nakano T, Takeshima T, Fukuhara Y, Yasui K, et al. Transcriptional activation of p62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson ' s disease. Brain Res 2004;1012:42-51. (Pubitemid 38648897)
167. Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 2008;106:107-120. (Pubitemid 351840194)
168. Weissman L, Jo DG, Sorensen MM, de Souza-Pinto NC, Markesbery WR, Mattson MP, Bohr VA. Defective DNA base excision repair in brain from individuals with Alzheimer ' s disease and amnestic mild cognitive impairment. Nucleic Acids Res 2007;35:5545-5555. (Pubitemid 47423927)
169. Dezor M, Dorszewska J, Florczak J, Kempisty B, Jaroszewska-Kolecka J, Rozycka A, et al. Expression of 8-oxoguanine DNA glycosylase 1 (OGG1) and the level of p53 and TNFalphalpha proteins in peripheral lymphocytes of patients with Alzheimer ' s disease. Folia Neuropathol 2011;49: 123-131.
170. Shao C, Xiong S, Li GM, Gu L, Mao G, Markesbery WR, Lovell MA. Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer ' s disease brain. Free Radic Biol Med 2008;45:813-819.
171. Weissman L, de Souza-Pinto NC, Mattson MP, Bohr VA. DNA base excision repair activities in mouse models of Alzheimer ' s disease. Neurobiol Aging 2009;30:2080-2081.
172. Gredilla R, Weissman L, Yang JL, Bohr VA, Stevnsner T. Mitochondrial base excision repair in mouse synaptosomes during normal aging and in a model of Alzheimer ' s disease. Neurobiol Aging 2010; doi:10.1016/j.neurobiolaging.2010. 1006.1019.
173. Kadioglu E, Sardas S, Aslan S, Isik E, Esat Karakaya A. Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer ' s disease. Biomarkers 2004;9: 203-209. (Pubitemid 39255641)
174. Mecocci P, Polidori MC, Ingegni T, Cherubini A, Chionne F, Cecchetti R, Senin U. Oxidative damage to DNA in lymphocytes from AD patients. Neurology 1998;51: 1014-1017. (Pubitemid 28473393)
175. Morocz M, Kalman J, Juhasz A, Sinko I, McGlynn AP, Downes CS, Janka Z, Rasko I. Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer ' s disease. Neurobiol Aging 2002;23:47-53. (Pubitemid 34070637)
176. Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer ' s disease ventricular CSF. J Neurochem 1999;72: 771-776. (Pubitemid 29055242)
177. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer ' s disease. J Neurochem 2005;93:953-962. (Pubitemid 40695754)
178. Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci 2008;31: 251-256.
179. Petrozzi L, Ricci G, Giglioli NJ, Siciliano G, Mancuso M. Mitochondria and neurodegeneration. Biosci Rep 2007;27: 87-104. (Pubitemid 46940938)